On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like Acerus Reports Fourth Quarter And Full Year 2016 Financial Results March 7, 2017 Kala Pharma Sinks on Mixed Data From Two Phase III Dry Eye Disease Studies January 4, 2018 Forensic Exam Shows Pattern in 4 Deaths of Sanofi Dengue Vaccine Recipients January 9, 2018
